Cell-based therapies for a variety of lung diseases can be considered safe, according to an analysis that pooled data from all available clinical trials of stem cell therapies. Although death rates were lower in treated patients compared to controls, findings did not indicate any statistically significant differences in either the…
Use of high-resolution computed tomography (HRCT) imaging technique can help identify features of thoracic sarcoidosis, researchers in India report. Because of its superior imaging capacity, they said, this method may allow clinicians to identify subtle chest abnormalities commonly undetectable by standard methods. The results were published in the study “…
Treatment with repository corticotropin (RCI), such as Acthar Gel, may protect the lungs from prednisone-induced damage and improve the outcome in patients with symptomatic pulmonary sarcoidosis, according to results of a clinical trial (NCT02188017). The findings, “Repository Corticotropin For Chronic Pulmonary Sarcoidosis.” were published in the journal Lung.
Loyola Medicine has just performed its 900th transplant, reaching a new milestone in its lung transplant program for patients with conditions affecting the lungs like sarcoidosis. Loyola has outperformed all other transplant centers in Illinois, with three times as many transplants as all the remaining centers combined. In 1988 the…
During Rare Disease Week 2017 on Capitol Hill, the nonprofit Foundation for Sarcoidosis Research (FSR) co-cohosted a briefing to members of Congress stressing the importance of National Sarcoidosis Awareness Month in April. The FSR says recognizing the month would draw more attention to, enhance awareness of, and promote more…
The third annual national awareness campaign “Seek Answers. Inspire Results” aims to bring attention to patients with sarcoidosis. The campaign, a collaboration between the CHEST Foundation and the Foundation of Sarcoidosis Research (FSR), is set to coincide with the National Sarcoidosis Awareness Month in April. Although sarcoidosis is a treatable condition…
An analysis of the usefulness of chest X-ray screening for sarcoidosis among patients with a certain type of eye inflammation (uveitis) failed to answer the question of whether it might be better to omit X-ray screening from initial evaluations in favor of more sensitive imaging techniques. Researchers stated that this failure…
Most patients with sarcoidosis have a similar risk of cancer compared to the general population, but some patients with more a more advanced form of the disease may have twice the risk of developing blood cancer, according to results from recent research. The study, “Risk Of Malignancy Among Patients With…
A recent review discussed other options besides prednisone and methotrexate in treating sarcoidosis, including antimetabolites similar in action to methotrexate, antimalarial agents, adrenocorticotropic hormone (ACTH) gel, biological agents, and antimycobacterial therapy, which is normally used to treat tuberculosis. The review, “Sarcoidosis: treatments beyond prednisone and methotrexate,” was published…
Intravenous immune globulin (IVIG) therapy, alone or combined with infliximab, may significantly ease symptoms of sarcoidosis-associated small fiber neuropathy (SSFN), according to a retrospective analysis study. The report, “Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment” was published…
Get regular updates to your inbox.